Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DA005367-03
Application #
3035216
Study Section
Drug Abuse Clinical and Behavioral Research Review Committee (DACB)
Project Start
1990-09-01
Project End
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost

  Institution

Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104

  Publications

Kirby, L G; Rowan, G A; Smith, R L et al. (1994) Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM). Psychopharmacology (Berl) 113:351-60
Prather, P L; Rezazadeh, S M; Lane, J D et al. (1993) Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal. J Pharmacol Exp Ther 264:622-30
Rowan, G A; Lucki, I (1992) Discriminative stimulus properties of the benzodiazepine receptor antagonist flumazenil. Psychopharmacology (Berl) 107:103-12
Emmett-Oglesby, M W; Rowan, G A (1991) Drug discrimination used to study drug withdrawal. NIDA Res Monogr :337-57
Rowan, G A; Lucki, I (1989) Discrimination of the benzodiazepine receptor antagonist Ro 15-1788 using the conditioned taste aversion procedure. NIDA Res Monogr 95:536